IRCT201008094179N3已完成未知
Effects of metformin and pioglitazone in polycystic ovarian syndrome
Vice-chancellor for research, Kermanshah University of Medical Science0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 49 years（—）
- 性别
- Female
入选标准
- •High TSH with FT4 in normal range
- •Exclusion criteria: receiving Levothyroxine, glucocorticoids, aspirin, amiodaron, lipid lowering agents, OCP, dopamine antagonist eg. metoclopramide and domperidone in recent 6 months, diabetic patients, pregnant women, women in menopause ages, patients older than 60 years
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Evaluation of effectiveness of Metformin and pioglitazone in women with polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovarian syndromeIRCT201403101836N7Shahid Sadoughi University of Medical Sciences75
进行中（未招募）
不适用
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb StudyEUCTR2007-006706-14-ATTakeda Pharma GmbH200
进行中（未招募）
不适用
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb StudyDiabetes mellitus type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-006706-14-DETakeda Pharma GmbH
已完成
不适用
Effect of pioglitazone and metformin in combination with insulin therapy in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000003830Chigasaki Municipal Hospital250
已完成
不适用
The use of metformin in patients with polycystic ovarian syndrome requiring treatment with in vitro fertilisation (IVF)rological and Genital Diseases: Polycystic ovarian syndrome (PCOS)Urological and Genital DiseasesPolycystic ovarian syndrome (PCOS)ISRCTN47219228Department of Health (UK)100